◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › AORT

Artivion, Inc. (AORT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-26

Artivion, Inc. (AORT) operates in the Medical Devices industry and is headquartered in Kennesaw, United States with about 1,800 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, AORT reported $441M in revenue and $10M in net income.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Interactive charts & full statements → Open the AORT valuation workbench →

AORT Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$441M$388M$354M$314M
Gross Profit$284M$249M$229M$202M
Operating Income (EBIT)$27M$39M($8M)$6M
Net Income$10M($13M)($31M)($19M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AORT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$116M$116M$113M$113M$99M
Gross Profit$75M$73M$74M$73M$64M
Operating Income (EBIT)$6M$7M$9M$8M$2M
Net Income$1M$2M$6M$1M($0M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AORT Free Cash Flow History

AORT Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$885M$789M$792M$763M
Total Liabilities$437M$513M$511M$478M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AORT viewer.

Other Companies in Medical Devices

← AONAll stocksAOS →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.